Vincent H. Wu

745 total citations
11 papers, 123 citations indexed

About

Vincent H. Wu is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Vincent H. Wu has authored 11 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 6 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in Vincent H. Wu's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers) and HIV/AIDS Research and Interventions (3 papers). Vincent H. Wu is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (5 papers) and HIV/AIDS Research and Interventions (3 papers). Vincent H. Wu collaborates with scholars based in United States, Senegal and Mexico. Vincent H. Wu's co-authors include Geoffrey S. Gottlieb, Dana N. Raugi, Moussa Seydi, Robert A. Smith, Selly Ba, Michael R. Betts, Son Nguyen, Perla M. Del Río Estrada, Santiago Ávila‐Ríos and Mauricio González-Navarro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Immunology.

In The Last Decade

Vincent H. Wu

8 papers receiving 122 citations

Peers

Countries citing papers authored by Vincent H. Wu

Since Specialization

Citations

This map shows the geographic impact of Vincent H. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent H. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent H. Wu more than expected).

Fields of papers citing papers by Vincent H. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent H. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent H. Wu. The network helps show where Vincent H. Wu may publish in the future.

Co-authorship network of co-authors of Vincent H. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent H. Wu. A scholar is included among the top collaborators of Vincent H. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent H. Wu. Vincent H. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset 2025 ·Nature Communications ·Gregory J. Golden, Vincent H. Wu, Jacob T. Hamilton, Kevin R. Amses, (unknown), Alberto Sada Japp, Chengyang Liu, M. Betina Pampena, Leticia Kuri-Cervantes, James J. Knox, (unknown), Mark A. Atkinson, Todd M. Brusko, Eline T. Luning Prak, Klaus H. Kaestner, Ali Naji, Michael R. Betts	1
2	Therapeutic CD8 ⁺ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound 2025 ·Proceedings of the National Academy of Sciences ·M. Betina Pampena, (unknown), Elise G. Viox, Kevin Nguyen, Claire Deléage, Leticia Kuri-Cervantes, James Regan, Vincent H. Wu, (unknown), Jeffrey T. Safrit, Katharine J. Bar, Brandon F. Keele, Miles P. Davenport, Mirko Paiardini, Michael R. Betts	0
3	Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ART 2025 ·bioRxiv (Cold Spring Harbor Laboratory) ·Vincent H. Wu, (unknown), M. Betina Pampena, Suzanna Rachimi, William Burgess, (unknown), Jake A. Robinson, Perla M. Del Río Estrada, Mariane Høgsbjerg Schleimann, (unknown), Mauricio González-Navarro, (unknown), (unknown), (unknown), Katharine J. Bar, Jacob D. Estes, Ole S. Søgaard, Neil Romberg, Santiago Ávila‐Ríos, Michael R. Betts	0
4	Growth factor–induced activation of MSK2 leads to phosphorylation of H3K9me2S10 and corresponding changes in gene expression 2024 ·Science Advances ·Karen Wong, (unknown), Vincent H. Wu, Anna A. Kiseleva, Jun Li, Andrey Poleshko, Cheryl L. Smith, Jonathan A. Epstein	0
5	Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir 2022 ·Nature Immunology ·Vincent H. Wu, (unknown), Son Nguyen, (unknown), (unknown), Perla M. Del Río Estrada, (unknown), Mauricio González-Navarro, (unknown), Santiago Ávila‐Ríos, Gustavo Reyes‐Terán, Pablo Tebas, Luis J. Montaner, Katharine J. Bar, Laura A. Vella, Michael R. Betts	53
6	Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity 2022 ·Cancer Immunology Research ·(unknown), Jack Y. Lee, Vincent H. Wu, (unknown), Bianca Nguyen, David A. Canton, (unknown)	1
7	Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations in HIV-2 Integrase: A Phenotypic Analysis Using an Expanded Panel of Site-Directed Mutants 2022 ·The Journal of Infectious Diseases ·Robert A. Smith, Vincent H. Wu, Jennifer Song, Dana N. Raugi, Khardiata Diallo Mbaye, Moussa Seydi, Geoffrey S. Gottlieb	4
8	Assessment of HIV-1 integration in tissues and subsets across infection stages 2020 ·JCI Insight ·Vincent H. Wu, Christopher L. Nobles, Leticia Kuri-Cervantes, Kevin McCormick, J.K. Everett, Son Nguyen, Perla M. Del Río Estrada, Mauricio González-Navarro, (unknown), Santiago Ávila‐Ríos, Gustavo Reyes‐Terán, Frederic D. Bushman, Michael R. Betts	15
9	In VitroAntiviral Activity of Cabotegravir against HIV-2 2018 ·Antimicrobial Agents and Chemotherapy ·Robert A. Smith, Vincent H. Wu, (unknown), Dana N. Raugi, Selly Ba, Moussa Seydi, Geoffrey S. Gottlieb	17
10	MK-8591 (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture 2017 ·Antimicrobial Agents and Chemotherapy ·Vincent H. Wu, Robert A. Smith, (unknown), Dana N. Raugi, Selly Ba, Moussa Seydi, Jay A. Grobler, Geoffrey S. Gottlieb	17
11	The Nucleoside Analog BMS-986001 Shows GreaterIn VitroActivity against HIV-2 than against HIV-1 2015 ·Antimicrobial Agents and Chemotherapy ·Robert A. Smith, Dana N. Raugi, Vincent H. Wu, (unknown), (unknown), (unknown), Papa Salif Sow, Selly Ba, Moussa Seydi, Geoffrey S. Gottlieb	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact